Publications by authors named "Paul D Miller"

Claim this Profile
"
"Conclusions from a KDIGO Controversies Conference" and CKD-MBD-associated osteoporosis.
Michael Pazianas, Paul D Miller

Kidney Int· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metal-Ligand Exchange Coupling Alters the Open-Shell Ligand Electronic Structure in a Bis(semiquinone) Complex.
Paul D Miller, Joshua Mengell, David A Shultz, Martin L Kirk

Inorg Chem· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rationale for intermittent administration of PTH in the management of mineral and bone disorder of chronic kidney disease.
Michael Pazianas, Paul D Miller

J Nephrol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation from closed-shell to open shell electronic structures in oligothiophene bis(dioxolene) complexes.
Paul D Miller, David A Shultz, Joshua Mengell, Martin L Kirk, Lukasz Wojtas

Chem Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Letter to the Editor: Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.
Paul D Miller, Zhigang Yu

J Bone Miner Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings of the 2022 Santa Fe Bone Symposium: Current Concepts in the Care of Patients with Osteoporosis and Metabolic Bone Diseases.
E Michael Lewiecki, John P Bilezikian, Neil Binkley, Mary L Bouxsein, Susan V Bukata, Paul D Miller

J Clin Densitom· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.
Paul D Miller, Jonathan D Adachi, Ben-Hur Albergaria, Angela M Cheung, Arkadi A Chines

J Bone Miner Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of osteoanabolic agents in the management of patients with osteoporosis.
Michael R McClung, Micol S Rothman, E Michael Lewiecki, David A Hanley, Steven T Harris, Paul D Miller

Postgrad Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuation of Bisphosphonate Therapy for Osteoporosis beyond 5 Years.
Leslie L Chang, Richard Eastell, Paul D Miller

N Engl J Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings of the 2021 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis and Metabolic Bone Diseases.
E Michael Lewiecki, Paul A Anderson, John P Bilezikian, Neil Binkley, Angela M Cheung, Paul D Miller

J Clin Densitom· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Burosumab for Tumor-Induced Osteomalacia: not Enough of a Good Thing.
Suzanne M Jan de Beur, Paul D Miller, Thomas J Weber, Munro Peacock, Karl Insogna

J Bone Miner Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics.
Michael Pazianas, Paul D Miller

Am J Kidney Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teriparatide: Label changes and identifying patients for long-term use.
Paul D Miller, E Michael Lewiecki, Kelly Krohn, Elliott Schwartz

Cleve Clin J Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burosumab for the Treatment of Tumor-Induced Osteomalacia.
Suzanne M Jan de Beur, Paul D Miller, Thomas J Weber, Munro Peacock, Karl Insogna

J Bone Miner Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With Osteoporosis.
David W Dempster, Hua Zhou, Sudhaker D Rao, Chris Recknor, Paul D Miller

J Bone Miner Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral Density.
Paul D Miller, Steven Troy, Richard J Weiss, Miriam Annett, Jason Schense

Clin Drug Investig· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum for Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study.
Ruban Dhaliwal, Didier Hans, Gary Hattersley, Bruce Mitlak, Lorraine A Fitzpatrick, Paul D Miller

JBMR Plus· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease.
Aaron Broadwell, Arkadi Chines, Peter R Ebeling, Edward Franek, Shuang Huang, Paul D Miller

J Clin Endocrinol Metab· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CKD-MBD Syndrome: Hysteresis in PTH Involvement and PTH Administration for Its Management.
Michael Pazianas, Paul D Miller

J Bone Miner Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis.
Paul D Miller, John P Bilezikian, Lorraine A Fitzpatrick, Bruce Mitlak, Eugene V McCloskey

Curr Med Res Opin· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
History of etidronate.
Nelson B Watts, Charles H Chesnut, Harry K Genant, Steven T Harris, Rebecca D Jackson, Paul D Miller

Bone· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study.
Ruban Dhaliwal, Didier Hans, Gary Hattersley, Bruce Mitlak, Lorraine A Fitzpatrick, Paul D Miller

JBMR Plus· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of Long-Term Efficacy of Denosumab Treatment in Postmenopausal Women With Osteoporosis: A FRAX- and Virtual Twin-Based Post Hoc Analysis From the FREEDOM and FREEDOM Extension Trials.
Ethel Siris, Michele McDermott, Nicola Pannacciulli, Paul D Miller, E Michael Lewiecki

JBMR Plus· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Understanding of Mineral and Bone Disorders of Chronic Kidney Disease and the Scientific Grounds on the Use of Exogenous Parathyroid Hormone in Its Management.
Michael Pazianas, Paul Dennis Miller

J Bone Metab· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response rates for hip, femoral neck, and lumbar spine bone mineral density in patients treated with abaloparatide followed by alendronate: Results from phase 3 ACTIVExtend.
Chad L Deal, Bruce H Mitlak, Yamei Wang, Lorraine A Fitzpatrick, Paul D Miller

Bone Rep· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis